Literature DB >> 1829387

Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro human skin explant model.

A M Dickinson1, L Sviland, J Dunn, P Carey, S J Proctor.   

Abstract

A human skin explant model was used to investigate the role of cytokines in graft-versus-host reactions (GVHR). Responder cells from HLA mismatched mixed lymphocyte cultures (MLC) produced GVHR (Grades I-III) in skin explant assays. Cell-free supernatants from these experiments also induced similar histopathological changes in the skin. The greatest degree of correlation between the GVHR observed with responder cells and the supernatant was shown with CD4 enriched MLC (p less than 0.001). Supernatants were assayed for tumour necrosis factor-alpha (TNF alpha) and interferon-gamma (IFN gamma) and CD4 enriched MLC populations produced high levels of these cytokines. These results correlated with the grade of GVHR observed in skin explant assays. The GVHR produced by the supernatant alone could be inhibited by both anti-IFN gamma and anti-TNF alpha polyclonal antibodies. The results suggest that TNF alpha and IFN gamma are directly involved in tissue damage during graft-versus-host disease in allogeneic transplant in man.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829387

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  9 in total

1.  Modulation of human interferon-gamma biosynthesis by antisense oligodeoxynucleotides.

Authors:  C M Boeve; M De Ley
Journal:  Mol Biotechnol       Date:  2000-02       Impact factor: 2.695

2.  NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects.

Authors:  Janelle A Olson; Dennis B Leveson-Gower; Saar Gill; Jeanette Baker; Andreas Beilhack; Robert S Negrin
Journal:  Blood       Date:  2010-03-16       Impact factor: 22.113

3.  A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation.

Authors:  L Sviland; A M Dickinson
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

Review 4.  Novel pharmacotherapeutic approaches to prevention and treatment of GVHD.

Authors:  David A Jacobsohn; Georgia B Vogelsang
Journal:  Drugs       Date:  2002       Impact factor: 9.546

5.  CD317-Positive Immune Stromal Cells in Human "Mesenchymal Stem Cell" Populations.

Authors:  Alasdair G Kay; James M Fox; James P Hewitson; Andrew P Stone; Sophie Robertson; Sally James; Xiao-Nong Wang; Elizabeth Kapasa; Xuebin B Yang; Paul G Genever
Journal:  Front Immunol       Date:  2022-06-06       Impact factor: 8.786

6.  Irradiation of the skin and systemic graft-versus-host disease synergize to produce cutaneous lesions.

Authors:  J Desbarats; T A Seemayer; W S Lapp
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

Review 7.  Graft-versus-host disease and the Th1/Th2 paradigm.

Authors:  W Krenger; J L Ferrara
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 8.  Insights into mechanisms of graft-versus-host disease through humanised mouse models.

Authors:  Amal Elhage; Chloe Sligar; Debbie Watson; Ronald Sluyter; Peter Cuthbertson
Journal:  Biosci Rep       Date:  2022-09-30       Impact factor: 3.976

9.  Immune reconstitution and graft-versus-host reactions in rat models of allogeneic hematopoietic cell transplantation.

Authors:  Severin Zinöcker; Ralf Dressel; Xiao-Nong Wang; Anne M Dickinson; Bent Rolstad
Journal:  Front Immunol       Date:  2012-11-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.